Tower Research Capital (TRC)’s VanEck AA-BB CLO ETF CLOB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
36,168
+33,529
+1,271% +$1.69M 0.05% 370
2025
Q4
$134K Buy
+2,639
New +$134K ﹤0.01% 1742
2025
Q3
Sell
-1,650
Closed -$83.9K 5721
2025
Q2
$83.9K Buy
+1,650
New +$82.7K ﹤0.01% 2524

Other funds holding CLOB

Tower Research Capital (TRC)'s CLOB Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its VanEck AA-BB CLO ETF (CLOB) stake by 1,271% in Q1 2026, buying an estimated $1.69M and bringing the position to 36,168 shares worth $1.81M. The position accounts for 0.05% of the portfolio, ranked #370.

Tower Research Capital (TRC) first reported a position in CLOB in Q2 2025 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold CLOB as of Q1 2026.

  • Tower Research Capital (TRC) held 36,168 shares of VanEck AA-BB CLO ETF worth $1.81M as of Q1 2026.
  • Tower Research Capital (TRC) bought 33,529 VanEck AA-BB CLO ETF shares in Q1 2026, an estimated $1.69M.
  • VanEck AA-BB CLO ETF made up 0.05% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #370 holding.
  • Tower Research Capital (TRC) first reported a position in VanEck AA-BB CLO ETF in Q2 2025 and has held it in 3 quarters since.
  • 24 funds tracked by Wall St. Rank held VanEck AA-BB CLO ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.